Olsen et al. investigated, in a report published in this issue of the journal, 1 the potential interaction between plasma total homocysteine and serum vitamin A (retinol) in relation to incident acute myocardial infarction. There were 2205 patients from western Norway undergoing elective coronary angiography for suspected stable angina pectoris in whom the prospective relationships between plasma total homocysteine and acute myocardial infarction were assessed by Cox regression. The hazard ratio (HR) per standard deviation (SD) increase in log-transformed plasma total homocysteine was the metrics. In addition, an interaction term for plasma total homocysteine times serum vitamin A was added to multivariate models including age, sex, smoking, apolipoprotein B and estimated glomerular filtration rate. To assess the interaction in the presence of competing risks, subdistribution HRs from identical models were computed. When plotting the HR of log-transformed plasma total homocysteine against a given range of vitamin A (0-7 mmol/L) it was nicely illustrated how the association of log-transformed plasma total homocysteine with acute myocardial infarction changes with increasing concentrations of vitamin A (see Figure 1 in Olsen et al.). Plasma total homocysteine was higher among participants in the upper versus lower serum vitamin A tertiles but C-reactive protein levels and estimated glomerular filtration rate were very significantly lower and the multivariate models accounted only for the latter. During approximately 7 years of follow-up, 15.1% suffered an acute myocardial infarction. A significant association of plasma total homocysteine with acute myocardial infarction incidence in the study population was observed, particularly so in the upper vitamin A tertile (HR per SD 1.29, 95% confidence interval (CI) 1.08-1.55; P interaction ¼ 0.02). The authors concluded from their exploratory study that the association of circulating concentrations of total homocysteine with incident acute myocardial infarction is confined to patients with elevated serum concentrations of vitamin A. They speculated that the total homocysteine-associated risk may reflect disturbed lipid metabolism, and thus experimental and mechanistic studies will be needed to elucidate this interaction in a biological system. The study is an interesting investigation that provides some new insights into the interaction between plasma total homocysteine and serum vitamin A, a hitherto unexplored area, in relation to incident acute myocardial infarction. The topic recently received some attention in the epidemiological area in relation to acute coronary syndromes or stroke.
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Olsen et al. investigated, in a report published in this issue of the journal, 1 the potential interaction between plasma total homocysteine and serum vitamin A (retinol) in relation to incident acute myocardial infarction. There were 2205 patients from western Norway undergoing elective coronary angiography for suspected stable angina pectoris in whom the prospective relationships between plasma total homocysteine and acute myocardial infarction were assessed by Cox regression. The hazard ratio (HR) per standard deviation (SD) increase in log-transformed plasma total homocysteine was the metrics. In addition, an interaction term for plasma total homocysteine times serum vitamin A was added to multivariate models including age, sex, smoking, apolipoprotein B and estimated glomerular filtration rate. To assess the interaction in the presence of competing risks, subdistribution HRs from identical models were computed. When plotting the HR of log-transformed plasma total homocysteine against a given range of vitamin A (0-7 mmol/L) it was nicely illustrated how the association of log-transformed plasma total homocysteine with acute myocardial infarction changes with increasing concentrations of vitamin A (see Figure 1 in Olsen et al.) . Plasma total homocysteine was higher among participants in the upper versus lower serum vitamin A tertiles but C-reactive protein levels and estimated glomerular filtration rate were very significantly lower and the multivariate models accounted only for the latter. During approximately 7 years of follow-up, 15.1% suffered an acute myocardial infarction. A significant association of plasma total homocysteine with acute myocardial infarction incidence in the study population was observed, particularly so in the upper vitamin A tertile (HR per SD 1.29, 95% confidence interval (CI) 1.08-1.55; P interaction ¼ 0.02). The authors concluded from their exploratory study that the association of circulating concentrations of total homocysteine with incident acute myocardial infarction is confined to patients with elevated serum concentrations of vitamin A. They speculated that the total homocysteine-associated risk may reflect disturbed lipid metabolism, and thus experimental and mechanistic studies will be needed to elucidate this interaction in a biological system. The study is an interesting investigation that provides some new insights into the interaction between plasma total homocysteine and serum vitamin A, a hitherto unexplored area, in relation to incident acute myocardial infarction. The topic recently received some attention in the epidemiological area in relation to acute coronary syndromes or stroke. [2] [3] [4] [5] [6] Reviews were also published on homocysteine-lowering interventions for preventing stroke 7 or cardiovascular events more in general, 8 but these were essentially based on vitamin B. There are, however, elements that forced a question mark in my comment.
First of all, baseline diets were not reported in detail and only retinol intake was considered, which was not significantly different in the three vitamin A tertiles although it was higher in the upper tertile. It is then difficult to ascertain whether provitamin intakes were implicated as the result of differential diets taken by the grouped individuals. Second, a missing exploration was about any different inflammatory agents potentially impacting on endothelium like uric acid as compared to C-reactive protein that was curiously lower in the upper vitamin A tertile and was not considered in the multivariable models. I believe that in future investigations these aspects should be addressed imperatively if one is either to accept or rule out the role of inflammatory indices as essential cofactors. Moreover, there are some trivial methodological issues. Indeed, a peculiar procedure was used 'The participants were followed from baseline to the date of AMI [acute myocardial infarction] diagnosis, death, or emigration or through December 31, 2009 (the end of follow-up), whichever came first.' Probably solutions whereby emigrations were instead considered as lost individuals should have been considered. Finally, fasting versus non-fasting (more than three-quarters of the samples) plasma levels were not double-checked in order to assess whether average plasma levels were comparable.
Cardiovascular disease, including coronary heart disease, stroke and peripheral vascular disease, is a leading cause of death worldwide. 9 Homocysteine is an amino acid with biological functions in methionine metabolism. When total circulating homocysteine levels increase there might be a higher risk of impaired endothelial function and thus an increased probability of thrombosis, also possibly leading to coronary calcification 10 under oxidative stress and inflammatory stimuli wherefrom vascular smooth muscle cells may undergo osteogenic differentiation thus setting the stage for acute coronary syndromes and strokes. 7, 8 To determine whether homocysteine-lowering interventions, given to patients with and without pre-existing cardiovascular disease in the form of vitamins B6, B9 or B12 supplements, alone or in combination compared with placebo, were effective in preventing cardiovascular events, as well as reducing all-cause mortality, and to evaluate their safety the Cochrane Central Register of Controlled Trials and other databases were searched up to June 2017 without language restriction in the search. Randomised controlled trials assessing the effects of homocysteine-lowering interventions for preventing cardiovascular events with a follow-up period of one year or longer were included. As primary outcomes either acute myocardial infarction or stroke were considered as the most representative cases whose aetiology is atherosclerosis. 11, 12 Among 15 randomised controlled trials involving 71,422 participants there were no differences in the effects of homocysteinelowering interventions on acute myocardial infarction, death from any cause, or serious adverse events. 8 However, compared with placebo, homocysteinelowering interventions were associated with reduced stroke outcome, thus confirming what was known previously. 4, 7 The effect was nevertheless quite small as approximately 143 (95% CI 85-428) people would need to be treated for 5.4 years to prevent one stroke. 8 The evidence concerning homocysteine as a lone risk factor in acute myocardial infarction patients is small and the association with outcome is quite fragile. Ma et al. 2 evaluated the association between hyperhomocysteinemia and the short-term outcomes of patients with acute myocardial infarction. Patients were divided into a high homocysteine level group (N ¼ 457) and a low homocysteine level group (N ¼ 348) based on a cut-off of 15 mmol/L. The incidences of heart failure, cardiac rupture, death and the total adverse cardiovascular events were statistically significantly higher in the high versus the low group. Xu et al.
3 investigated 20,424 hypertensive patients (60 AE 7 years, 41% men) without a history of myocardial infarction or stroke who had total homocysteine levels of 14 AE 8 mmol/L. After a mean follow-up period of 4.5 years, there were 612 (3%) all-cause deaths. Kaplan-Meier survival curves showed a graded relationship between total homocysteine quartiles and all-cause mortality. A linear trend test, using natural log-transformed total homocysteine, resulted in a HR of 1.5 (95% CI 1.2-1.9, P < 0.001) after adjustment for lifestyle and health-related variables and the association was subject to effect modification by MTHFR genotypes. Dhar et al. 5 and other co-authors from the commented paper 1 merged subjects from two independent cohort studies, the Western Norway Coronary Angiography Cohort (WECAC) (3033 patients with stable angina pectoris; 263 events within 4.8 years of median follow-up) and the Norwegian Vitamin Trial (NORVIT) (3670 patients with acute myocardial infarction; 683 events within 3.2 years of median follow-up) and compared the cystathionine quartile 4 to 1, age and gender adjusted HRs (95% CI) for acute myocardial infarction were 2.08 (1.43-3.03) and 1.41 (1.12-1.76) in WECAC and NORVIT, respectively. Additional adjustment for traditional risk factors slightly attenuated the risk estimates, which were generally stronger in both cohorts among non-smokers, patients with higher age and lower body mass index. Risk associations also tended to be stronger in patients not treated with B vitamins. In addition, in a subset of 80 WECAC patients, plasma cystathionine associated strongly negatively with glutathione, an important antioxidant and positively with lanthionine, pointing to altered redox homeostasis. More recently, Chen et al. 6 prospectively enrolled ST-segment elevation myocardial infarction (STEMI) patients (N ¼ 56) who were consecutively admitted to an intensive care unit following coronary intervention in a single medical centre in Taiwan. Control subjects were individuals who presented to the outpatient or emergency department with acute chest pain but subsequently revealed patent coronary arteries by coronary arteriography (N ¼ 17). They assessed the association between serum homocysteine levels and STEMI. Homocysteine was not elevated in STEMI patients regardless of Killip severity, suggesting that homocysteine is a bystander instead of a causative factor.
The large majority of coronary patients in Europe do not achieve the guideline standards for secondary prevention with high prevalences of persistent smoking, unhealthy diets and physical inactivity, and consequently most patients are overweight or obese with a high prevalence of diabetes. 13 Risk factor control is inadequate despite a high reported use of medications, and there are large variations in secondary prevention practice between centres. Less than half of the coronary patients access cardiac prevention and rehabilitation programmes. 13 On the other hand, serum concentrations of folate, vitamin B12 and total homocysteine were determined from blood samples obtained from 3010 Blue Mountains Eye Study participants (1997) (1998) (1999) , aged 55 years and older by Gopinath et al., 14 whereby coronary heart disease and all-cause mortality was confirmed using the Australian National Death Index. Serum total homocysteine and folate were independent predictors of coronary heart disease and allcause mortality, while vitamin B12 was not associated. It was concluded that as raised total homocysteine levels and folate deficiency are associated with poorer lifestyles, changes to a more healthy lifestyle among older adults may minimise the adverse vascular effects of elevated total homocysteine. That a healthy lifestyle, including no smoking, physical exercise and a Mediterranean diet may prolong life is an established fact of preventive cardiology, [15] [16] [17] and the Seven Countries Study in particular provided at individual 18 and more recently at ecological [19] [20] [21] levels the scientific bases for this evidence: individual saturated fatty acids, overall fat and dietary cholesterol intake were directly associated with coronary heart disease mortality, whereas this was not the case for oleic acid and polyunsaturated fatty acids, whereas carbohydrate intake was signiEcantly correlated with low coronary heart disease rates. These Endings were paralleled by the direct and significant correlation between saturated fatty acids and mean serum cholesterol and between serum cholesterol levels and coronary heart disease incidence and mortality. 18 All these Endings are compatible with a causal hypothesis that diets high in saturated fat intake (leading to high average levels of serum cholesterol) were responsible for a greater incidence and mortality rates from coronary heart disease across populations. 21 A clear contrast was seen between cohorts from North America and northern Europe on the one side, and those of Japan and southern Europe on the other, mainly the Mediterranean areas. 18 Similar analyses were made for the intake of Favonoids that represent an important category of antioxidant agents of vegetable origin. These micronutrients were inversely correlated with 25-year coronary heart disease death rates in 16 cohorts (linear correlation coefEcient -0.50). Other analyses combined selected items, either nutrient or food groups. In an ecological analysis of alcohol, Esh, Ebre and antioxidant vitamins (b-carotene, vitamin C and vitamin E) versus 25-year mortality from coronary heart disease, alcohol and Esh were inversely related to coronary heart disease mortality, but became non-signiEcant when saturated fat and smoking were simultaneously considered. Fibre and antioxidant vitamins were not related to coronary heart disease mortality. 18 In another analysis, saturated fatty acids and vitamin C were considered together with smoking habits as a possible confounder. In a 25-year follow-up for all-cause mortality, the intake of saturated fat was directly associated with mortality risk, while vitamin C was inversely related. 18 There are two sources of dietary vitamin A: active forms, which are immediately available to the body and are obtained from animal products. These are known as retinoids and include retinaldehyde and retinol. Precursors, also known as provitamins, which must be converted to active forms by the body, are obtained from fruits and vegetables containing yellow, orange and dark green pigments, known as carotenoids, the most well known being b-carotene. For this reason, amounts of vitamin A are measured in retinol equivalents (REs). One RE is equivalent to 0.001 mg of retinol, or 0.006 mg of b-carotene, or 3.3 international units of vitamin A. All sources of vitamin A can provide retinol, but retinoids are found naturally in some foods of animal origin. Each of the following contains at least 0.15 mg of retinoids per 50-198 g: cod liver oil, butter, liver (beef, pork, chicken, turkey, fish), eggs, cheese and milk. It is therefore extremely important to document the diet of people in whom vitamin A determinations are made for whatever reason because the actual RE might be very different based on the differential diets consumed.
Finally, and not least a very recent but small investigation by Markovic´Boras et al. 22 determined interestingly the relationship of homocysteine, uric acid and C-reactive protein in the serum of 85 patients with acute myocardial infarction prior to application of percutaneous coronary intervention and their level of correlation in the serum of patients with normal and elevated C-reactive protein (as a predictor of worse cardiovascular outcomes). Elevated levels of both homocysteine and uric acid in acute myocardial infarction patients as well as a positive correlation between homocysteine and uric acid levels were observed. Classification of patients on the basis of mean uric acid concentration showed a significant difference at the level of homocysteine concentration (P ¼ 0.022). The authors concluded that considering a potential link between all parameters observed, further research involving a greater number of patients and including the post-treatment effects should be conducted, a very important message in view of the predictive role of uric acid for long-term cardiovascular events in residential cohorts (much more than estimated glomerular filtration rate) 23, 24 and among patients with acute myocardial infarction. 25 In conclusion, although the submitted hypothesis was that the total homocysteine-associated risk of acute myocardial infarction may reflect disturbed lipid metabolism (with higher low-density lipoprotein cholesterol, ApoB and ApoA1 levels), mainly at the hepatic level, as the result of higher vitamin A levels, it is unclear why inflammatory indices such as C-reactive protein were lower in the upper tertile of vitamin A. This factor was not considered in multivariable solutions (like estimated glomerular filtration rate that instead was) and other important indices such as uric acid were not measured at all. Finally, although retinol intake was measured and was not different among vitamin A tertiles, while being higher in the upper tertile, the lack of consideration of full dietary information in the enrolled patients demands further studies and justifies a still pending expectation as related to the association among vitamin A levels, total homocysteine and the incidence of acute myocardial infarction whose implicated pathophysiological mechanisms remain elusive.
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